Literature DB >> 27236775

Bilateral periprosthetic joint infection with Ureaplasma urealyticum in an immunocompromised patient.

R L Roerdink1, C M Douw2, A C A P Leenders2, R S Dekker2, M Dietvorst2, C J M Oosterbos3, H T J Roerdink4, R W T M Kempen3, L P A Bom2.   

Abstract

This case study discusses how we diagnosed and treated a patient with a late haematogenous bilateral periprosthetic joint infection (PJI) after total knee arthroplasties caused by Ureaplasma urealyticum. This has never been reported before. We will discuss how we used a PET-CT, synovial fluid cell count, and synovial fluid analysis by 16S rRNA gene sequencing to diagnose this PJI. We will also discuss how we treated this patient to obtain full recovery.

Entities:  

Keywords:  16S rRNA; Immunocompromised; Infection; PJI; Prosthetic; Ureaplasma

Mesh：

Year:  2016        PMID： 27236775     DOI： 10.1007/s15010-016-0912-0

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  16 in total

1.  The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis.

Authors:  Hany Bedair; Nicholas Ting; Christina Jacovides; Arjun Saxena; Mario Moric; Javad Parvizi; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

2.  Characteristics and treatment outcomes of 69 cases with early prosthetic joint infections of the hip and knee.

Authors:  Y Achermann; P Stasch; S Preiss; K Lucke; M Vogt
Journal:  Infection       Date:  2014-01-29       Impact factor: 3.553

3.  Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.

Authors:  Z Samra; S Rosenberg; M Dan
Journal:  J Chemother       Date:  2011-04       Impact factor: 1.714

Review 4.  How to approach neutropenia.

Authors:  Laurence A Boxer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

5.  Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.

Authors:  E Presterl; A J Grisold; S Reichmann; A M Hirschl; A Georgopoulos; W Graninger
Journal:  J Antimicrob Chemother       Date:  2004-11-24       Impact factor: 5.790

Review 6.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

7.  FDG PET for diagnosing infection in hip and knee prostheses: prospective study in 221 prostheses and subgroup comparison with combined (111)In-labeled leukocyte/(99m)Tc-sulfur colloid bone marrow imaging in 88 prostheses.

Authors:  Sandip Basu; Thomas C Kwee; Babak Saboury; Jonathan P Garino; Charles L Nelson; Hongming Zhuang; Molly Parsons; Wengen Chen; Rakesh Kumar; Ali Salavati; Thomas J Werner; Abass Alavi
Journal:  Clin Nucl Med       Date:  2014-07       Impact factor: 7.794

Review 8.  Suppression of normal immune responses after treatment with rituximab.

Authors:  Ruba Kado; Georgiana Sanders; W Joseph McCune
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

Review 9.  Prosthetic joint infection.

Authors:  Aaron J Tande; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  The "true" incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study.

Authors:  Per Hviid Gundtoft; Søren Overgaard; Henrik Carl Schønheyder; Jens Kjølseth Møller; Per Kjærsgaard-Andersen; Alma Becic Pedersen
Journal:  Acta Orthop       Date:  2015-01-30       Impact factor: 3.717
View more
  3 in total

Review 1.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

2.  Clostridium difficile septic arthritis and periprosthetic joint infection in a patient with acute lymphoblastic leukaemia, T-/B-lymphocytopenia and hypogammaglobulinemia - a case report and review of the literature.

Authors:  Daniel Karczewski; Maximilian Müllner; Carsten Perka; Michael Müller
Journal:  Access Microbiol       Date:  2021-05-10

Review 3.  Invasive Ureaplasma Infection in Patients Receiving Rituximab and Other Humoral Immunodeficiencies-A Case Report and Review of the Literature.

Authors:  Vimal V Jhaveri; Mary T Lasalvia
Journal:  Open Forum Infect Dis       Date:  2019-09-10       Impact factor: 3.835
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.